Genetic Factors Affecting Skin Reactions in Breast Cancer Patients After Radiation Therapy
Author Information
Author(s): Falvo Elisabetta, Strigari Lidia, Citro Gennaro, Giordano Carolina, Arcangeli Stefano, Soriani Antonella, D'Alessio Daniela, Muti Paola, Blandino Giovanni, Sperduti Isabella, Pinnarò Paola
Primary Institution: Regina Elena National Cancer Institute, Rome, Italy
Hypothesis
The study aims to evaluate the association between polymorphisms in DNA repair and oxidative stress genes and the risk of developing erythema in breast cancer patients following radiation therapy.
Conclusion
Certain genetic polymorphisms and the mean dose of radiation to the breast can predict the occurrence of erythema in breast cancer patients after treatment.
Supporting Evidence
- 33% of patients developed grade 1 or 2 erythema after treatment.
- Univariate analysis showed significant risk factors for erythema related to specific gene variants.
- Multivariate analysis confirmed the mean dose to the breast and certain gene variants as predictors of erythema.
Takeaway
Some people might get red skin after breast cancer treatment because of their genes and how much radiation they receive.
Methodology
The study involved assessing acute toxicity in breast cancer patients using specific genetic tests and statistical analyses to correlate gene variants with skin reactions.
Limitations
The study's findings need to be confirmed in larger cohorts.
Participant Demographics
Median age of participants was 66 years, with a mix of ductal and other histologies.
Statistical Information
P-Value
0.002, 0.006, 0.031
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website